Crossmark

Response to “Before taurine is recommended for stroke-like episodes in m.3243A > G carriers, its efficacy must be demonstrated by appropriate studies”

Crossref DOI link: https://doi.org/10.1007/s13730-026-01112-7

Published Online: 2026-04-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yoshida, Ryuto

Mitsuno, Ryunosuke

Azegami, Tatsuhiko

Yamaguchi, Shintaro https://orcid.org/0000-0002-4917-033X
Hayashi, Kaori
License Information

Text and Data Mining valid from 2026-04-07

Version of Record valid from 2026-04-07
More Information

Article History

Received: 10 March 2026

Accepted: 16 March 2026

First Online: 7 April 2026

Declarations

:

: All the authors have declared no competing interest.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: Informed consent was obtained from the patient for publication of this case report and all accompanying images.

Document is current

Any future updates will be listed below